Evotec SE Logo

Evotec SE

ISIN: DE0005664809 | Ticker: EVT | LEI: 529900F9KI6OYITO9B12
Sector: Health CareSub-Industry: Health Care Facilities
Country: Germany

About Evotec SE

Company Description

Evotec is a life science company with a unique business model that delivers on its mission to discover and develop highly effective therapeutics and make them available to the patients. The Company’s multimodality platform comprises a unique combination of innovative technologies, data and science for the discovery, development, and production of first-in-class and best-in-class pharmaceutical products. Evotec leverages this "Data-driven R&D Autobahn to Cures" for proprietary projects and within a network of partners including all Top 20 Pharma and over 800 biotechnology companies, academic institutions, as well as other healthcare stakeholders. Evotec has strategic activities in a broad range of currently underserved therapeutic areas, including e.g. neurology, oncology, as well as metabolic and infectious diseases.

Year founded

1993

Served area

Worldwide

Headcount

3,030

Headquarters

Essener Bogen 7, 22419 Hamburg – Germany

Filings & Publications

2021

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / GER
GER / ENG
GER / ENG
GER / ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2020

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
ENG / GER
GER / ENG
ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2019

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
GER / ENG
GER / ENG
GER / ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2018

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / GER
GER / ENG
ENG / GER
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2022

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
ENG
ENG
Corporate Governance Report
Company Presentation
ENG / GER
GER / ENG
ENG
Sustainability Report
Remuneration Report

2017

Report
Q1
H1
Q3
FY
Consolidated Report
ENG / GER
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

2016

Report
Q1
H1
Q3
FY
Consolidated Report
GER / ENG
Corporate Governance Report
Company Presentation
Sustainability Report
Remuneration Report

Insider Trades

Date Trading entity / Person Association Trade type Volume
12.02.24 Dohrmann, Dr. Cord Board Sell EUR 272,025.13
22.01.24 Lanthaler, Dr. Werner Board Sell EUR 397,543.19
18.01.24 Lanthaler, Dr. Werner Board Other EUR 159,141.96
18.01.24 Lanthaler, Dr. Werner Board Other EUR 131,792.04
18.01.24 Dohrmann, Dr. Cord Board Other EUR 87,387.85
18.01.24 Johnstone, Dr. Craig Board Other EUR 51,611.51
18.01.24 Johnstone, Dr. Craig Board Other EUR 51,596.02
18.01.24 Johnstone, Dr. Craig Board Other EUR 42,730.20
18.01.24 Johnstone, Dr. Craig Board Other EUR 42,715.44
18.01.24 Dohrmann, Dr. Cord Board Other EUR 24,855.84

Capital markets information

ISIN

DE0005664809

LEI

529900F9KI6OYITO9B12

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Providers & Services

Sub-Industry

Health Care Facilities

Designated Sponsor

Oddo BHF Corporates & Markets AG

Listed Stock Exchange

Frankfurt Stock Exchange

Stock Index

MDAX

TecDAX

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.